133,802 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Mackenzie Financial Corp

Mackenzie Financial Corp bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 133,802 shares of the company's stock, valued at approximately $7,144,000. Mackenzie Financial Corp owned 0.07% of Doximity as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. FMR LLC increased its stake in shares of Doximity by 37.6% during the fourth quarter. FMR LLC now owns 9,409,313 shares of the company's stock valued at $502,363,000 after acquiring an additional 2,571,580 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in Doximity by 708.7% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock worth $80,641,000 after buying an additional 1,323,634 shares in the last quarter. Invesco Ltd. increased its stake in shares of Doximity by 525.1% during the 4th quarter. Invesco Ltd. now owns 1,272,403 shares of the company's stock worth $67,934,000 after purchasing an additional 1,068,849 shares during the last quarter. Franklin Resources Inc. increased its stake in shares of Doximity by 1,178.3% during the 4th quarter. Franklin Resources Inc. now owns 1,062,211 shares of the company's stock worth $56,711,000 after purchasing an additional 979,113 shares during the last quarter. Finally, Fundsmith LLP bought a new position in shares of Doximity in the 4th quarter valued at approximately $37,934,000. Institutional investors own 87.19% of the company's stock.

Insider Activity

In related news, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at $20,440,552.95. This trade represents a 11.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the transaction, the director now directly owns 16,618 shares in the company, valued at approximately $946,062.74. The trade was a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms recently weighed in on DOCS. Raymond James decreased their target price on Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Truist Financial dropped their target price on shares of Doximity from $58.00 to $52.00 and set a "hold" rating for the company in a research note on Friday, May 16th. Needham & Company LLC reduced their price objective on shares of Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research note on Friday, May 16th. Mizuho dropped their target price on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a report on Friday, May 16th. Finally, Piper Sandler raised Doximity from a "neutral" rating to an "overweight" rating and boosted their price target for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Doximity has a consensus rating of "Moderate Buy" and a consensus price target of $61.89.

Doximity Stock Up 0.5%

DOCS traded up $0.28 during trading on Friday, reaching $52.22. 1,471,453 shares of the stock traded hands, compared to its average volume of 2,096,508. Doximity, Inc. has a 12 month low of $25.00 and a 12 month high of $85.21. The stock has a market capitalization of $9.75 billion, a PE ratio of 52.22, a P/E/G ratio of 4.10 and a beta of 1.41. The stock's 50-day moving average is $55.39 and its 200 day moving average is $58.08.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The business's revenue for the quarter was up 17.1% on a year-over-year basis. During the same quarter last year, the company posted $0.25 earnings per share. As a group, equities research analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.